Cargando…

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome

BACKGROUND: To further our understanding of immunopeptidomics, improved tools are needed to identify peptides presented by major histocompatibility complex class I (MHC-I). Many existing tools are limited by their reliance upon chemical affinity data, which is less biologically relevant than samplin...

Descripción completa

Detalles Bibliográficos
Autores principales: Boehm, Kevin Michael, Bhinder, Bhavneet, Raja, Vijay Joseph, Dephoure, Noah, Elemento, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321722/
https://www.ncbi.nlm.nih.gov/pubmed/30611210
http://dx.doi.org/10.1186/s12859-018-2561-z
_version_ 1783385509849989120
author Boehm, Kevin Michael
Bhinder, Bhavneet
Raja, Vijay Joseph
Dephoure, Noah
Elemento, Olivier
author_facet Boehm, Kevin Michael
Bhinder, Bhavneet
Raja, Vijay Joseph
Dephoure, Noah
Elemento, Olivier
author_sort Boehm, Kevin Michael
collection PubMed
description BACKGROUND: To further our understanding of immunopeptidomics, improved tools are needed to identify peptides presented by major histocompatibility complex class I (MHC-I). Many existing tools are limited by their reliance upon chemical affinity data, which is less biologically relevant than sampling by mass spectrometry, and other tools are limited by incomplete exploration of machine learning approaches. Herein, we assemble publicly available data describing human peptides discovered by sampling the MHC-I immunopeptidome with mass spectrometry and use this database to train random forest classifiers (ForestMHC) to predict presentation by MHC-I. RESULTS: As measured by precision in the top 1% of predictions, our method outperforms NetMHC and NetMHCpan on test sets, and it outperforms both these methods and MixMHCpred on new data from an ovarian carcinoma cell line. We also find that random forest scores correlate monotonically, but not linearly, with known chemical binding affinities, and an information-based analysis of classifier features shows the importance of anchor positions for our classification. The random-forest approach also outperforms a deep neural network and a convolutional neural network trained on identical data. Finally, we use our large database to confirm that gene expression partially determines peptide presentation. CONCLUSIONS: ForestMHC is a promising method to identify peptides bound by MHC-I. We have demonstrated the utility of random forest-based approaches in predicting peptide presentation by MHC-I, assembled the largest known database of MS binding data, and mined this database to show the effect of gene expression on peptide presentation. ForestMHC has potential applicability to basic immunology, rational vaccine design, and neoantigen binding prediction for cancer immunotherapy. This method is publicly available for applications and further validation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-018-2561-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6321722
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63217222019-01-09 Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome Boehm, Kevin Michael Bhinder, Bhavneet Raja, Vijay Joseph Dephoure, Noah Elemento, Olivier BMC Bioinformatics Methodology Article BACKGROUND: To further our understanding of immunopeptidomics, improved tools are needed to identify peptides presented by major histocompatibility complex class I (MHC-I). Many existing tools are limited by their reliance upon chemical affinity data, which is less biologically relevant than sampling by mass spectrometry, and other tools are limited by incomplete exploration of machine learning approaches. Herein, we assemble publicly available data describing human peptides discovered by sampling the MHC-I immunopeptidome with mass spectrometry and use this database to train random forest classifiers (ForestMHC) to predict presentation by MHC-I. RESULTS: As measured by precision in the top 1% of predictions, our method outperforms NetMHC and NetMHCpan on test sets, and it outperforms both these methods and MixMHCpred on new data from an ovarian carcinoma cell line. We also find that random forest scores correlate monotonically, but not linearly, with known chemical binding affinities, and an information-based analysis of classifier features shows the importance of anchor positions for our classification. The random-forest approach also outperforms a deep neural network and a convolutional neural network trained on identical data. Finally, we use our large database to confirm that gene expression partially determines peptide presentation. CONCLUSIONS: ForestMHC is a promising method to identify peptides bound by MHC-I. We have demonstrated the utility of random forest-based approaches in predicting peptide presentation by MHC-I, assembled the largest known database of MS binding data, and mined this database to show the effect of gene expression on peptide presentation. ForestMHC has potential applicability to basic immunology, rational vaccine design, and neoantigen binding prediction for cancer immunotherapy. This method is publicly available for applications and further validation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-018-2561-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-05 /pmc/articles/PMC6321722/ /pubmed/30611210 http://dx.doi.org/10.1186/s12859-018-2561-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Boehm, Kevin Michael
Bhinder, Bhavneet
Raja, Vijay Joseph
Dephoure, Noah
Elemento, Olivier
Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title_full Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title_fullStr Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title_full_unstemmed Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title_short Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
title_sort predicting peptide presentation by major histocompatibility complex class i: an improved machine learning approach to the immunopeptidome
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321722/
https://www.ncbi.nlm.nih.gov/pubmed/30611210
http://dx.doi.org/10.1186/s12859-018-2561-z
work_keys_str_mv AT boehmkevinmichael predictingpeptidepresentationbymajorhistocompatibilitycomplexclassianimprovedmachinelearningapproachtotheimmunopeptidome
AT bhinderbhavneet predictingpeptidepresentationbymajorhistocompatibilitycomplexclassianimprovedmachinelearningapproachtotheimmunopeptidome
AT rajavijayjoseph predictingpeptidepresentationbymajorhistocompatibilitycomplexclassianimprovedmachinelearningapproachtotheimmunopeptidome
AT dephourenoah predictingpeptidepresentationbymajorhistocompatibilitycomplexclassianimprovedmachinelearningapproachtotheimmunopeptidome
AT elementoolivier predictingpeptidepresentationbymajorhistocompatibilitycomplexclassianimprovedmachinelearningapproachtotheimmunopeptidome